The Application of Lifestyle Enhancing Validated Integrative Therapies for Everyday Pain in Cirrhosis

Part of paid clinical trials in San Francisco, California.

Sponsor
University of Pennsylvania
Study ID
NCT07792850
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cirrhoses, Liver

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • High-touch self-management program — BEHAVIORAL
    Tailored digital self-management program, individualized pain coaching, and a structured walking or meditation curriculum selected through Active Choice as the primary behavioral focus for 48 weeks. On-demand coaching for low-pain self-efficacy and optional group coaching sessions.
  • Low-touch self-management program — BEHAVIORAL
    Access to the self-guided digital self-management platform with automated educational content and behavioral nudges for 48 weeks.

Study Details

The goal of this clinical trial is to test a low-touch vs high-touch drug-free pain self-management program that may help lower pain and improve quality of life for adults with cirrhosis and pain. Participants are assigned by chance to one of two study groups. The groups receive different levels of support. The main questions it aims to answer are: * Do the programs help lower pain? * Do the programs improve quality of life? * Is one program more effective than the other? Researchers will compare a low-touch self management program to a high-touch self-management program to see if the programs help manage pain. Participants in the low-touch arm will: * Learn new ways to manage pain without medication * Receive access to the self-guided digital self-management platform * Receive general behavioral text message nudges * Receive a free Fitbit to keep Participants in the high-touch arm will: * Learn new ways to manage pain without medication * Receive tailored access to the self-guided digital self-management platform * Received individualized pain coaching and optional group coaching sessions * Participate in a structured walking or meditation curriculum * Receive a free Fitbit to keep

Key Dates

First listed
Aug 28, 2026
Start date
Jan 1, 2027
Status verified
Aug 2026
Primary completion
Mar 1, 2030
Completion
Jun 1, 2030

Study Design

Enrollment
625 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: High-Touch
    Participants receive tailored digital self-management program, individualized pain coaching, and a structured walking or meditation curriculum selected through Active Choice as the primary behavioral focus for 48 weeks. The high-touch arm also includes on-demand coaching for low-pain self-efficacy and optional group coaching sessions.
  • Experimental: Low-Touch
    Participants receive access to the self-guided digital self-management platform with automated educational content and behavioral nudges for 48 weeks.

Primary Outcome Measure

Pain Interference [ Time Frame: 48 weeks ]

Locations (8)

FacilityCityStateZIPSite coordinators
University of California San FranciscoSan FranciscoCalifornia94143
Rayshawnda Davis, MS
Jessica Rubin, MD, MPH (PRINCIPAL_INVESTIGATOR)
University of MiamiMiamiFlorida33136
Cindy Delgado
305-243-5799
David Goldberg, MD (PRINCIPAL_INVESTIGATOR)
John Hopkins UniversityBaltimoreMaryland21205
Lisa Datta
(443) 831-1940
Alexandra Strauss, MD, PhD (PRINCIPAL_INVESTIGATOR)
University of MichiganAnn ArborMichigan48109
Samantha Nikirk, MPH
7342324182
Elliot Tapper, MD (PRINCIPAL_INVESTIGATOR)
Mayo ClinicRochesterMinnesota55905
Amy Olofson, RN
(507) 538-6547
Douglas Simonetto, MD (PRINCIPAL_INVESTIGATOR)
Columbia UniversityNew YorkNew York10032
Geena Heitmann, MPH
(212) 305-3839
Elizabeth Verna, MD (PRINCIPAL_INVESTIGATOR)
University of PennsylvaniaPhiladelphiaPennsylvania19104
Richard Mason, PharmD
215-349-8986
Jacqueline Theroux, MPH
2156623904
Marina Serper, MD, MS (PRINCIPAL_INVESTIGATOR)
Vanderbilt UniversityNashvilleTennessee37232
Ashley Spann, MD, MS
(615) 421-6137
Ashley Spann, MD, MS (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Francisco, CA